418 related articles for article (PubMed ID: 12703177)
21. Interventional palliative treatment options for lung cancer.
Noppen N
Ann Oncol; 2002; 13 Suppl 4():247-50. PubMed ID: 12401697
[No Abstract] [Full Text] [Related]
22. Invited commentary.
Fieguth HG
Ann Thorac Surg; 2005 Sep; 80(3):1026-7. PubMed ID: 16122478
[No Abstract] [Full Text] [Related]
23. [Interferon therapy of the lung and locoregional therapy in pulmology].
Pohl WR
Wien Med Wochenschr; 1993; 143(16-17):450-4. PubMed ID: 7505989
[TBL] [Abstract][Full Text] [Related]
24. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
Van Meerbeeck JP; De Pauw R; Tournoy K
Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
[TBL] [Abstract][Full Text] [Related]
25. [The effect of haemoglobin levels on prognosis and quality of life of patients with bronchial carcinoma].
Drings P; Wannenmacher M
Dtsch Med Wochenschr; 2005 Jun; 130(24):1507-11. PubMed ID: 15942841
[TBL] [Abstract][Full Text] [Related]
26. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
van Meerbeeck JP; Surmont VF
Lung Cancer; 2009 Sep; 65(3):257-67. PubMed ID: 19285751
[TBL] [Abstract][Full Text] [Related]
27. [Diagnostic strategy and treatment planning in bronchial cancer].
Drings P
Radiologe; 1990 Apr; 30(4):149-54. PubMed ID: 2160669
[TBL] [Abstract][Full Text] [Related]
28. [Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version].
Goeckenjan G; Sitter H; Thomas M; Branscheid D; Flentje M; Griesinger F; Niederle N; Stuschke M; Blum T; Deppermann KM; Ficker JH; Freitag L; Lübbe AS; Reinhold T; Späth-Schwalbe E; Ukena D; Wickert M; Wolf M; Andreas S; Auberger T; Baum RP; Baysal B; Beuth J; Bickeböller H; Böcking A; Bohle RM; Brüske I; Burghuber O; Dickgreber N; Diederich S; Dienemann H; Eberhardt W; Eggeling S; Fink T; Fischer B; Franke M; Friedel G; Gauler T; Gütz S; Hautmann H; Hellmann A; Hellwig D; Herth F; Heussel CP; Hilbe W; Hoffmeyer F; Horneber M; Huber RM; Hübner J; Kauczor HU; Kirchbacher K; Kirsten D; Kraus T; Lang SM; Martens U; Mohn-Staudner A; Müller KM; Müller-Nordhorn J; Nowak D; Ochmann U; Passlick B; Petersen I; Pirker R; Pokrajac B; Reck M; Riha S; Rübe C; Schmittel A; Schönfeld N; Schütte W; Serke M; Stamatis G; Steingräber M; Steins M; Stoelben E; Swoboda L; Teschler H; Tessen HW; Weber M; Werner A; Wichmann HE; Irlinger Wimmer E; Witt C; Worth H; ;
Pneumologie; 2011 Aug; 65(8):e51-75. PubMed ID: 21830177
[No Abstract] [Full Text] [Related]
29. A seismic shift in staging.
Silvestri GA
J Thorac Oncol; 2007 Aug; 2(8):682-3. PubMed ID: 17762332
[No Abstract] [Full Text] [Related]
30. Lung cancer in North Carolina.
Rimer BK; Herman D; Crawford J; Blackwell S
N C Med J; 1993 Jul; 54(7):334-40. PubMed ID: 8394512
[No Abstract] [Full Text] [Related]
31. Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer.
Van Schil PE
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):718; author reply 718-9. PubMed ID: 18329516
[No Abstract] [Full Text] [Related]
32. [Chemotherapy in cancer of the lung].
Gütz S
MMW Fortschr Med; 2006 Jun; 148(22):33-4. PubMed ID: 16821578
[TBL] [Abstract][Full Text] [Related]
33. Stage II (T3) lung cancer.
Allen MS; Jett JR; Kozelsky TF
Chest Surg Clin N Am; 2001 Feb; 11(1):61-7. PubMed ID: 11253601
[TBL] [Abstract][Full Text] [Related]
34. Lung cancer treatment. No easy answers.
Mayo Clin Health Lett; 2001 May; 19(5):4-5. PubMed ID: 11349635
[No Abstract] [Full Text] [Related]
35. Primary surgery revisited in very limited small cell lung cancer: does it have a role? A commentary.
Sorensen M
Lung Cancer; 2006 Jun; 52(3):263-4. PubMed ID: 16677735
[No Abstract] [Full Text] [Related]
36. Lung and mediastinum.
Curr Opin Oncol; 1991 Apr; 3(2):396-420. PubMed ID: 1648974
[No Abstract] [Full Text] [Related]
37. Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis.
Matakidou A; El Galta R; Rudd MF; Webb EL; Bridle H; Eisen T; Houlston RS
Br J Cancer; 2007 Jun; 96(12):1904-7. PubMed ID: 17519899
[TBL] [Abstract][Full Text] [Related]
38. Auditing a new lung cancer service.
Cullen JP; Glynn C; Murtagh E; Hogan B; Jeffers M; Lane SJ
Ir Med J; 2004 Oct; 97(9):281-3. PubMed ID: 15568588
[TBL] [Abstract][Full Text] [Related]
39. Treatment of recurrent disease in lung cancer.
Zimmermann FB; Molls M; Jeremic B
Semin Surg Oncol; 2003; 21(2):122-7. PubMed ID: 14508862
[TBL] [Abstract][Full Text] [Related]
40. Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer.
D'Angelillo RM; Trodella L; Ramella S
J Thorac Cardiovasc Surg; 2004 Sep; 128(3):489-90. PubMed ID: 15354115
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
